A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.

<h4>Background</h4>The risks attributed to drug-herb interactions, even when known, are often ignored or underestimated, especially for those involving anti-clotting drugs and Chinese medicines. The aim of this study was to structurally search and evaluate the existing evidence-based dat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hsin-Hui Tsai, Hsiang-Wen Lin, Ying-Hung Lu, Yi-Ling Chen, Gail B Mahady
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3af44712560141a782c4e4868b745d92
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3af44712560141a782c4e4868b745d92
record_format dspace
spelling oai:doaj.org-article:3af44712560141a782c4e4868b745d922021-11-18T07:46:09ZA review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.1932-620310.1371/journal.pone.0064255https://doaj.org/article/3af44712560141a782c4e4868b745d922013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23671711/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The risks attributed to drug-herb interactions, even when known, are often ignored or underestimated, especially for those involving anti-clotting drugs and Chinese medicines. The aim of this study was to structurally search and evaluate the existing evidence-based data associated with potential drug interactions between anticoagulant/antiplatelet drugs and Chinese herbal medicines (CHMs) and evaluate the documented mechanisms, consequences, and/or severity of interactions.<h4>Methodology and findings</h4>Information related to anticoagulant/antiplatelet drug-CHM interactions was retrieved from eight interaction-based textbooks, four web resources and available primary biomedical literature. The primary literature searches were conducted in English and/or Chinese from January 2000 through December 2011 using the secondary databases (e.g., PubMed, Airiti Library, China Journal full-text database). The search terms included the corresponding medical subject headings and key words. Herbs or natural products not used as a single entity CHM or in Chinese Medicinal Prescriptions were excluded from further review. The corresponding mechanisms and severity ratings of interactions were retrieved using MicroMedex®, Lexicomp® and Natural Medicines Comprehensive Database®. Finally, we found 90 single entity CHMs contributed to 306 documented drug-CHM interactions. A total of 194 (63.4%) interactions were verified for its evidence describing possible mechanisms and severity. Of them, 155 interactions (79.9%) were attributable to pharmacodynamic interactions, and almost all were rated as moderate to severe interactions. The major consequences of these interactions were increased bleeding risks due to the additive anticoagulant or antiplatelet effects of the CHMs, specifically danshen, dong quai, ginger, ginkgo, licorice, and turmeric.<h4>Conclusions/significance</h4>Conventional anticoagulants and antiplatelet drugs were documented to have harmful interactions with some commonly used single entity CHMs. For those patients who are taking conventional anti-clotting medications with CHMs for cardiovascular or cerebrovascular diseases, the potential risks of increased bleeding due to drug-CHM interactions should not be ignored.Hsin-Hui TsaiHsiang-Wen LinYing-Hung LuYi-Ling ChenGail B MahadyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 5, p e64255 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hsin-Hui Tsai
Hsiang-Wen Lin
Ying-Hung Lu
Yi-Ling Chen
Gail B Mahady
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.
description <h4>Background</h4>The risks attributed to drug-herb interactions, even when known, are often ignored or underestimated, especially for those involving anti-clotting drugs and Chinese medicines. The aim of this study was to structurally search and evaluate the existing evidence-based data associated with potential drug interactions between anticoagulant/antiplatelet drugs and Chinese herbal medicines (CHMs) and evaluate the documented mechanisms, consequences, and/or severity of interactions.<h4>Methodology and findings</h4>Information related to anticoagulant/antiplatelet drug-CHM interactions was retrieved from eight interaction-based textbooks, four web resources and available primary biomedical literature. The primary literature searches were conducted in English and/or Chinese from January 2000 through December 2011 using the secondary databases (e.g., PubMed, Airiti Library, China Journal full-text database). The search terms included the corresponding medical subject headings and key words. Herbs or natural products not used as a single entity CHM or in Chinese Medicinal Prescriptions were excluded from further review. The corresponding mechanisms and severity ratings of interactions were retrieved using MicroMedex®, Lexicomp® and Natural Medicines Comprehensive Database®. Finally, we found 90 single entity CHMs contributed to 306 documented drug-CHM interactions. A total of 194 (63.4%) interactions were verified for its evidence describing possible mechanisms and severity. Of them, 155 interactions (79.9%) were attributable to pharmacodynamic interactions, and almost all were rated as moderate to severe interactions. The major consequences of these interactions were increased bleeding risks due to the additive anticoagulant or antiplatelet effects of the CHMs, specifically danshen, dong quai, ginger, ginkgo, licorice, and turmeric.<h4>Conclusions/significance</h4>Conventional anticoagulants and antiplatelet drugs were documented to have harmful interactions with some commonly used single entity CHMs. For those patients who are taking conventional anti-clotting medications with CHMs for cardiovascular or cerebrovascular diseases, the potential risks of increased bleeding due to drug-CHM interactions should not be ignored.
format article
author Hsin-Hui Tsai
Hsiang-Wen Lin
Ying-Hung Lu
Yi-Ling Chen
Gail B Mahady
author_facet Hsin-Hui Tsai
Hsiang-Wen Lin
Ying-Hung Lu
Yi-Ling Chen
Gail B Mahady
author_sort Hsin-Hui Tsai
title A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.
title_short A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.
title_full A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.
title_fullStr A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.
title_full_unstemmed A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.
title_sort review of potential harmful interactions between anticoagulant/antiplatelet agents and chinese herbal medicines.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/3af44712560141a782c4e4868b745d92
work_keys_str_mv AT hsinhuitsai areviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT hsiangwenlin areviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT yinghunglu areviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT yilingchen areviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT gailbmahady areviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT hsinhuitsai reviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT hsiangwenlin reviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT yinghunglu reviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT yilingchen reviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
AT gailbmahady reviewofpotentialharmfulinteractionsbetweenanticoagulantantiplateletagentsandchineseherbalmedicines
_version_ 1718422963083018240